Rituximab treatment in Chinese patients with primary angiitis of the central nervous system
Our data suggest that RTX therapy may be an additional treatment option for Chinese patients with PACNS.
Authors
- Huabing Wang (ORCID: https://orcid.org/0000-0002-6848-2590)
- Yuzhen Wei (ORCID: https://orcid.org/0000-0003-4701-5157)
- Lulin Zhang (ORCID: https://orcid.org/0000-0003-1478-5737)
- Jiali Sun
- Xinghu Zhang (ORCID: https://orcid.org/0000-0002-5977-8648)
- De‐Cai Tian (ORCID: https://orcid.org/0000-0002-5153-2491)
- Ping Lü (ORCID: https://orcid.org/0000-0003-1962-588X)
- Linlin Yin (ORCID: https://orcid.org/0000-0001-6708-0621)
Institutions
- Capital Medical University (CN)
- Beijing Tian Tan Hospital (CN)
- National Clinical Research Center for Digestive Diseases (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-03-25
- DOI
- https://doi.org/10.3389/fneur.2025.1554989
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00